Funding news
LaNova Medicines logo

LaNova Medicines Raises $200.

Recently funded · $200.0M UnknownTechnology, Information and MediaView source

Get the full LaNova Medicines company profile

Access contacts, investors, buying signals & more

Open in Dashboard

LaNova Medicines, the Shanghai-based biotechnology firm focused on novel biologic drugs for cancer treatment, has secured $200.0M in new capital. The clinical-stage company, founded in 2019, is committed to discovering and developing innovative treatments, aiming to address the unmet clinical needs of cancer patients.

Leveraging proprietary technology platforms and a deep understanding of the tumor microenvironment, LaNova Medicines has built a differentiated pipeline of products. The company, led by industry veterans, operates as an R&D engine, striving to progress its programs toward the clinic.

Other recently funded companies

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Pacific Edge Ltd logo

Pacific Edge Ltd

New Zealand

$14.3M
2
Arib logo

Arib

Saudi Arabia

$23.5M
3
Jiusheng(TEC)electric co., ltd. logo

Jiusheng(TEC)electric co., ltd.

China

$427.0M
4
XbotGo logo

XbotGo

United States

$13.8M
5
Choco Up logo

Choco Up

Singapore

$30.0M